HEADER HYDROLASE 22-NOV-10 3POH TITLE CRYSTAL STRUCTURE OF AN ENDO-BETA-N-ACETYLGLUCOSAMINIDASE (BT_3987) TITLE 2 FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.55 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACTEROIDES THETAIOTAOMICRON; SOURCE 3 ORGANISM_TAXID: 226186; SOURCE 4 STRAIN: 226186; SOURCE 5 GENE: BT_3987; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS TIM BARREL, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL KEYWDS 2 GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 3 01-FEB-23 3POH 1 REMARK SEQADV LINK REVDAT 2 20-JUL-11 3POH 1 KEYWDS REVDAT 1 29-DEC-10 3POH 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF AN ENDO-BETA-N-ACETYLGLUCOSAMINIDASE JRNL TITL 2 (BT_3987) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.55 JRNL TITL 3 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0110 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 62730 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.138 REMARK 3 R VALUE (WORKING SET) : 0.136 REMARK 3 FREE R VALUE : 0.164 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3178 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.59 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4104 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.61 REMARK 3 BIN R VALUE (WORKING SET) : 0.1800 REMARK 3 BIN FREE R VALUE SET COUNT : 233 REMARK 3 BIN FREE R VALUE : 0.1920 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3325 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 5 REMARK 3 SOLVENT ATOMS : 612 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.66 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.34000 REMARK 3 B22 (A**2) : 0.34000 REMARK 3 B33 (A**2) : -0.51000 REMARK 3 B12 (A**2) : 0.17000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.069 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.040 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.173 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.975 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.962 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3715 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2485 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5124 ; 1.511 ; 1.967 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6172 ; 0.927 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 535 ; 6.078 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 172 ;38.445 ;25.581 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 642 ;11.471 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;16.035 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 572 ; 0.098 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4318 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 730 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2317 ; 1.523 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 943 ; 0.450 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3780 ; 2.436 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1398 ; 3.660 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1293 ; 5.558 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 42 A 476 REMARK 3 ORIGIN FOR THE GROUP (A): 56.7396 19.5617 63.7909 REMARK 3 T TENSOR REMARK 3 T11: 0.0223 T22: 0.0139 REMARK 3 T33: 0.0249 T12: -0.0120 REMARK 3 T13: 0.0044 T23: -0.0140 REMARK 3 L TENSOR REMARK 3 L11: 0.5002 L22: 0.4103 REMARK 3 L33: 0.4680 L12: 0.2288 REMARK 3 L13: -0.0231 L23: -0.0242 REMARK 3 S TENSOR REMARK 3 S11: -0.0474 S12: 0.0540 S13: -0.0242 REMARK 3 S21: -0.0581 S22: 0.0445 S23: -0.0304 REMARK 3 S31: 0.0128 S32: -0.0235 S33: 0.0029 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1.HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2.A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 3.ATOM RECORDS CONTAIN SUM OF TLS AND RESIDUAL B REMARK 3 FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U REMARK 3 FACTORS. 4.WATERS WERE EXCLUDED FROM AUTOMATIC TLS ASSIGNMENT. REMARK 3 5.IMIDAZOLE (IMD) FROM THE CRYSTALLIZATION SOLUTION HAS BEEN REMARK 3 MODELED IN THE SOLVENT STRUCTURE. REMARK 4 REMARK 4 3POH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-NOV-10. REMARK 100 THE DEPOSITION ID IS D_1000062624. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-OCT-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537,0.9795,0.9793 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62783 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 29.712 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.7600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.35700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.0M NACITRATE, 0.1M IMIDAZOLE PH 8.0, REMARK 280 NANODROP, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.63767 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 89.27533 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 89.27533 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 44.63767 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CRYSTAL PACKING ANALYSIS SUPPORTS THE ASSIGNMENT OF A REMARK 300 MONOMER AS THE SIGNIFICANT OLIGOMERIC STATE IN SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 ASP A 27 REMARK 465 ASP A 28 REMARK 465 LEU A 29 REMARK 465 GLU A 30 REMARK 465 VAL A 31 REMARK 465 GLY A 32 REMARK 465 LYS A 33 REMARK 465 ASN A 34 REMARK 465 ILE A 35 REMARK 465 ASP A 36 REMARK 465 GLU A 37 REMARK 465 SER A 38 REMARK 465 ALA A 39 REMARK 465 TYR A 40 REMARK 465 SER A 41 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 97 CG CD OE1 OE2 REMARK 470 LYS A 101 CG CD CE NZ REMARK 470 GLU A 142 CG CD OE1 OE2 REMARK 470 LYS A 166 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE ARG A 139 O HOH A 645 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 106 48.29 -146.91 REMARK 500 ASN A 276 49.95 -162.86 REMARK 500 GLN A 284 32.28 -144.97 REMARK 500 TYR A 315 0.95 81.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD A 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 417165 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS CONSTRUCT (RESIDUES 27-476) WAS EXPRESSED WITH A PURIFICATION REMARK 999 TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3POH A 27 476 UNP Q8A0N4 Q8A0N4_BACTN 27 476 SEQADV 3POH GLY A 0 UNP Q8A0N4 EXPRESSION TAG SEQRES 1 A 451 GLY ASP ASP LEU GLU VAL GLY LYS ASN ILE ASP GLU SER SEQRES 2 A 451 ALA TYR SER GLY ILE TYR GLU ASN ASN ALA TYR LEU ARG SEQRES 3 A 451 ASP GLY LYS SER ASN LEU VAL SER LYS VAL VAL GLU LEU SEQRES 4 A 451 HIS GLY GLU THR TYR ALA THR THR VAL LYS MSE GLY LEU SEQRES 5 A 451 SER LYS THR PRO ASN THR ALA THR SER ALA LYS VAL LYS SEQRES 6 A 451 ILE ASP ALA ALA TYR LEU GLU THR TYR ASN LYS ALA HIS SEQRES 7 A 451 ASN THR ASP PHE ALA LEU TYR PRO GLN ASP LEU VAL THR SEQRES 8 A 451 PHE ALA ASN GLU GLY ILE LEU THR VAL ASN ALA ASN THR SEQRES 9 A 451 LYS SER ALA GLU VAL GLU MSE THR ILE ARG ALA GLY GLU SEQRES 10 A 451 GLY LEU GLN GLU ASP LYS THR TYR ALA ILE PRO VAL ALA SEQRES 11 A 451 ILE SER ASP GLN SER SER ASP ILE THR ILE LYS ASP GLU SEQRES 12 A 451 ASP ALA LYS HIS CYS ILE TYR LEU VAL LYS ASP MSE ARG SEQRES 13 A 451 ASN ALA GLY ASP ALA TYR LYS GLY GLU GLY VAL MSE GLN SEQRES 14 A 451 GLY TYR LEU PHE PHE GLU VAL ASN ASP VAL ASN PRO LEU SEQRES 15 A 451 ASN THR LEU SER PHE GLN LEU GLU ASN GLY LYS LEU LEU SEQRES 16 A 451 TRP ASP VAL VAL VAL LEU PHE ALA ALA ASN ILE ASN TYR SEQRES 17 A 451 ASP ALA GLU ALA GLY ARG PRO ARG VAL GLN CYS ASN PRO SEQRES 18 A 451 ASN VAL GLN TYR LEU LEU ASP ASN ASN GLU THR LEU LEU SEQRES 19 A 451 GLN PRO LEU ARG ARG ARG GLY VAL LYS VAL LEU LEU GLY SEQRES 20 A 451 LEU LEU GLY ASN HIS ASP ILE THR GLY LEU ALA GLN LEU SEQRES 21 A 451 SER GLU GLN GLY ALA LYS ASP PHE ALA ARG GLU VAL ALA SEQRES 22 A 451 GLN TYR CYS LYS ALA TYR ASN LEU ASP GLY VAL ASN TYR SEQRES 23 A 451 ASP ASP GLU TYR SER ASN SER PRO ASP LEU SER ASN PRO SEQRES 24 A 451 SER LEU THR ASN PRO SER THR ALA ALA ALA ALA ARG LEU SEQRES 25 A 451 CYS TYR GLU THR LYS GLN ALA MSE PRO ASP LYS LEU VAL SEQRES 26 A 451 THR VAL PHE ASP TRP GLY GLN MSE TYR GLY VAL ALA THR SEQRES 27 A 451 VAL ASP GLY VAL ASP ALA LYS GLU TRP ILE ASP ILE VAL SEQRES 28 A 451 VAL ALA ASN TYR GLY SER ALA ALA TYR PRO ILE GLY GLN SEQRES 29 A 451 MSE THR LYS LYS GLN CYS SER GLY ILE SER MSE GLU PHE SEQRES 30 A 451 ASN LEU GLY GLY GLY GLY SER LEU SER ALA SER LYS ALA SEQRES 31 A 451 GLN SER MSE ILE ASP GLY GLY TYR GLY TRP PHE MSE GLY SEQRES 32 A 451 PHE ALA PRO SER PRO ALA LYS TYR GLY SER VAL PHE SER SEQRES 33 A 451 ARG LEU GLN GLY GLY GLY GLU VAL LEU TYR GLY SER ASN SEQRES 34 A 451 VAL ALA ALA PRO THR ILE PHE TYR LYS LYS ASN ASP PRO SEQRES 35 A 451 THR PRO TYR LYS TYR PRO ASP ASP LEU MODRES 3POH MSE A 75 MET SELENOMETHIONINE MODRES 3POH MSE A 136 MET SELENOMETHIONINE MODRES 3POH MSE A 180 MET SELENOMETHIONINE MODRES 3POH MSE A 193 MET SELENOMETHIONINE MODRES 3POH MSE A 345 MET SELENOMETHIONINE MODRES 3POH MSE A 358 MET SELENOMETHIONINE MODRES 3POH MSE A 390 MET SELENOMETHIONINE MODRES 3POH MSE A 400 MET SELENOMETHIONINE MODRES 3POH MSE A 418 MET SELENOMETHIONINE MODRES 3POH MSE A 427 MET SELENOMETHIONINE HET MSE A 75 8 HET MSE A 136 8 HET MSE A 180 8 HET MSE A 193 8 HET MSE A 345 8 HET MSE A 358 8 HET MSE A 390 8 HET MSE A 400 8 HET MSE A 418 8 HET MSE A 427 8 HET IMD A 500 5 HETNAM MSE SELENOMETHIONINE HETNAM IMD IMIDAZOLE FORMUL 1 MSE 10(C5 H11 N O2 SE) FORMUL 2 IMD C3 H5 N2 1+ FORMUL 3 HOH *612(H2 O) HELIX 1 1 ASP A 92 ASN A 104 1 13 HELIX 2 2 PRO A 111 ASP A 113 5 3 HELIX 3 3 ASN A 119 ILE A 122 5 4 HELIX 4 4 ALA A 127 THR A 129 5 3 HELIX 5 5 ASP A 167 LYS A 171 1 5 HELIX 6 6 ASN A 205 PHE A 212 5 8 HELIX 7 7 ASN A 245 ASN A 254 1 10 HELIX 8 8 ASN A 254 LEU A 259 1 6 HELIX 9 9 LEU A 259 ARG A 265 1 7 HELIX 10 10 SER A 286 TYR A 304 1 19 HELIX 11 11 SER A 330 MSE A 345 1 16 HELIX 12 12 LYS A 370 TRP A 372 5 3 HELIX 13 13 THR A 391 GLN A 394 5 4 HELIX 14 14 SER A 411 GLY A 422 1 12 HELIX 15 15 SER A 432 ALA A 434 5 3 HELIX 16 16 LYS A 435 ARG A 442 1 8 HELIX 17 17 GLY A 445 GLY A 452 1 8 SHEET 1 A 3 VAL A 115 PHE A 117 0 SHEET 2 A 3 SER A 131 ARG A 139 -1 O THR A 137 N THR A 116 SHEET 3 A 3 THR A 124 ASN A 126 -1 N ASN A 126 O SER A 131 SHEET 1 B 5 VAL A 115 PHE A 117 0 SHEET 2 B 5 SER A 131 ARG A 139 -1 O THR A 137 N THR A 116 SHEET 3 B 5 THR A 68 LEU A 77 -1 N MSE A 75 O ALA A 132 SHEET 4 B 5 ASN A 46 ASP A 52 -1 N ARG A 51 O LYS A 74 SHEET 5 B 5 ILE A 163 THR A 164 1 O THR A 164 N ASN A 46 SHEET 1 C 4 SER A 59 LEU A 64 0 SHEET 2 C 4 HIS A 172 ASP A 179 1 O LYS A 178 N LEU A 64 SHEET 3 C 4 THR A 149 SER A 157 -1 N TYR A 150 O VAL A 177 SHEET 4 C 4 LYS A 88 ILE A 91 -1 N LYS A 90 O ALA A 155 SHEET 1 D 4 SER A 59 LEU A 64 0 SHEET 2 D 4 HIS A 172 ASP A 179 1 O LYS A 178 N LEU A 64 SHEET 3 D 4 THR A 149 SER A 157 -1 N TYR A 150 O VAL A 177 SHEET 4 D 4 ALA A 108 LEU A 109 1 N ALA A 108 O ALA A 151 SHEET 1 E 6 ARG A 239 GLN A 243 0 SHEET 2 E 6 VAL A 223 ASP A 234 -1 N ASN A 230 O GLN A 243 SHEET 3 E 6 LYS A 268 LEU A 274 1 O LEU A 270 N VAL A 224 SHEET 4 E 6 GLY A 308 ASP A 312 1 O ASN A 310 N LEU A 273 SHEET 5 E 6 LEU A 349 PHE A 353 1 O PHE A 353 N TYR A 311 SHEET 6 E 6 ILE A 375 VAL A 377 1 O VAL A 377 N VAL A 352 SHEET 1 F 5 ARG A 239 GLN A 243 0 SHEET 2 F 5 VAL A 223 ASP A 234 -1 N ASN A 230 O GLN A 243 SHEET 3 F 5 GLN A 194 GLU A 200 1 N LEU A 197 O VAL A 225 SHEET 4 F 5 TRP A 425 PHE A 429 1 O GLY A 428 N PHE A 198 SHEET 5 F 5 SER A 396 GLU A 401 1 N GLY A 397 O TRP A 425 SHEET 1 G 2 THR A 363 VAL A 364 0 SHEET 2 G 2 VAL A 367 ASP A 368 -1 O VAL A 367 N VAL A 364 SHEET 1 H 2 ILE A 460 PHE A 461 0 SHEET 2 H 2 TYR A 470 LYS A 471 -1 O TYR A 470 N PHE A 461 LINK C LYS A 74 N MSE A 75 1555 1555 1.33 LINK C MSE A 75 N GLY A 76 1555 1555 1.32 LINK C GLU A 135 N MSE A 136 1555 1555 1.33 LINK C MSE A 136 N THR A 137 1555 1555 1.34 LINK C ASP A 179 N MSE A 180 1555 1555 1.33 LINK C MSE A 180 N ARG A 181 1555 1555 1.32 LINK C VAL A 192 N MSE A 193 1555 1555 1.32 LINK C MSE A 193 N GLN A 194 1555 1555 1.31 LINK C ALA A 344 N MSE A 345 1555 1555 1.33 LINK C MSE A 345 N PRO A 346 1555 1555 1.34 LINK C GLN A 357 N MSE A 358 1555 1555 1.33 LINK C MSE A 358 N TYR A 359 1555 1555 1.33 LINK C GLN A 389 N MSE A 390 1555 1555 1.33 LINK C MSE A 390 N THR A 391 1555 1555 1.34 LINK C SER A 399 N MSE A 400 1555 1555 1.32 LINK C MSE A 400 N GLU A 401 1555 1555 1.33 LINK C SER A 417 N MSE A 418 1555 1555 1.33 LINK C MSE A 418 N ILE A 419 1555 1555 1.32 LINK C PHE A 426 N MSE A 427 1555 1555 1.32 LINK C MSE A 427 N GLY A 428 1555 1555 1.32 CISPEP 1 PHE A 227 ALA A 228 0 1.57 CISPEP 2 TYR A 472 PRO A 473 0 -1.53 SITE 1 AC1 6 VAL A 58 TYR A 95 ASP A 169 HIS A 172 SITE 2 AC1 6 HOH A 903 HOH A 929 CRYST1 74.449 74.449 133.913 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013432 0.007755 0.000000 0.00000 SCALE2 0.000000 0.015510 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007468 0.00000